Search

everythinglearnresearchcommunity

for

Search:↓

Stem cells and their exosomes show promise for repairing tissues and healing wounds when delivered effectively, but more research is needed on their tracking and optimal use.

New treatments for skin conditions show promise, especially Coacillium® for hair growth in young people with alopecia areata.

The 2015 Hair Research Congress concluded that stem cells, maraviroc, and simvastatin could potentially treat Alopecia Areata, topical minoxidil, finasteride, and steroids could treat Frontal Fibrosing Alopecia, and PTGDR2 antagonists could also treat alopecia. They also found that low-level light therapy could help with hair loss, a robotic device could assist in hair extraction, and nutrition could aid hair growth. They suggested that Alopecia Areata is an inflammatory disorder, not a single disease, indicating a need for personalized treatments.

Mitochondrial dysfunction links metabolic syndrome and inflammatory skin diseases, suggesting targeted therapies and lifestyle changes.

Wharton's jelly-derived stem cells were safely used to treat four alopecia patients, resulting in hair regrowth in all of them.

Progeroid mouse models show signs of early aging similar to humans, helping us understand aging better.

The hydrogel with silver and ibuprofen promotes wound healing and fights infection.

Low-level laser therapy may help stem cells grow and function better, aiding in healing and tissue repair.

Microneedles are a promising method for drug delivery, offering efficient and convenient alternatives with fewer side effects.

Umbilical cord blood is a valuable source of stem cells for medical treatments, but its use is less common than other transplants, and there are ethical issues to consider.

COVID-19 has widely affected health, various industries, and the economy, but also led to more remote work and less pollution.

Patient-derived melanocytes can potentially treat vitiligo by restoring skin pigmentation.

New targets for making and using brain-synthesized steroids could lead to better treatments for brain disorders and alcoholism.

Regenerative cellular therapies show promise for treating non-scarring hair loss but need more research.

Secondary syphilis in Cali, Colombia, shows high Treponema pallidum presence and challenges in early diagnosis, needing better public health strategies.

A man with both Klinefelter syndrome and primary hyperparathyroidism showed a rare combination of symptoms and genetic patterns.

Using CRISPR for gene editing in the body is promising but needs better delivery methods to be more efficient and specific.

A family got a fungal infection from a boy who had contact with rabbits, but they all recovered with treatment.

Researchers found that certain lipids, especially vitamin D3, are lower in prematurely grey hair than in pigmented hair.

Certain leukemia drugs can cause severe skin reactions that may require stopping treatment.

Mice with a virus similar to COVID-19 had skin damage, but a special treatment helped repair it.

Microneedle technology has advanced for painless drug delivery and sensitive detection but faces a gap between experimental use and clinical needs.

New liposome treatment successfully delivers CRISPR to deactivate a key enzyme in androgen-related disorders.

Peptide-based hydrogels are promising for healing chronic wounds effectively.

Hair graying is influenced by factors like nerves, fat cells, and immune cells, not just hair follicles.

The main prostate diseases in dogs are benign growth, infections, and cancer, with various treatments ranging from drugs to surgery, but cancer treatments have limited success.

hsa-miR-193a-5p may help diagnose and treat alopecia areata.

Runx genes are important for stem cell regulation and their roles in aging and disease need more research.

Terbinafine effectively treated kerion celsi despite disrupted immune responses.

Autoimmune and inflammatory processes are involved in both scarring and non-scarring types of hair loss.